title: H1N1 vaccination: expect the unexpected.
authors.affiliation: Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands. c.popa@reuma.umcn.nl
authors.forename: C
authors.initials: C
authors.lastname: Popa
authors.forename: P C
authors.initials: PC
authors.lastname: Wever
authors.forename: M
authors.initials: M
authors.lastname: Moviat
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003015:Clostridium Infections / Q000175:diagnosis*; D052557:Clostridium septicum / Q000302:isolation & purification; D005260:Female; D005436:Floxacillin / Q000627:therapeutic use; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control; D012772:Shock, Septic / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000900:Anti-Bacterial Agents; D007252:Influenza Vaccines; D005436:Floxacillin; D002939:Ciprofloxacin